Topic: Sanjay Kaul
8/8/2007 Print E-mail The debate over the heart-attack risks posed by the type 2 diabetes drug Avandia has taken another twist, with a new study questioning the results of the research that kick-started the controversy.. In a study published June 14 in ...
7/10/2007 Print E-mail Nearly a third of patients who had drug-coated stents implanted in vein grafts to improve coronary blood flow died within 32 months, Dutch cardiologists report.. "We really do not have definitive evidence whether drug-eluting [coated] stents work in this ...
